Indiana University Melvin and Bren Simon Cancer Center is a clinical research site located in Indianapolis, Indiana, United States 46202-5289.
Crixeo Clinical Trials Trust Score: 90/100 (GOOD). This profile has not yet been claimed by the site owner.
Indiana University Melvin and Bren Simon Cancer Center has participated in 479 clinical trials with 165 currently active.
Therapeutic areas: Lymphoma, Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8.
Sponsors: Children's Oncology Group, National Cancer Institute (NCI), H. Lee Moffitt Cancer Center and Research Institute.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Indiana · View every site in Indianapolis
Trust Score: 90/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Indiana University Melvin and Bren Simon Cancer Center has a Crixeo Trust Score of 90/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Indiana University Melvin and Bren Simon Cancer Center has 479 clinical trials on record, with 165 currently active. Their work covers Lymphoma, Pathologic Stage I Cutaneous Merkel Cell Carcinoma AJCC v8, Pathologic Stage II Cutaneous Merkel Cell Carcinoma AJCC v8.
Indiana University Melvin and Bren Simon Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.